Meta Biomed Co., Ltd. (KOSDAQ:059210)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,610.00
-170.00 (-2.94%)
Last updated: Oct 29, 2025, 1:58 PM KST
-2.94%
Market Cap151.66B
Revenue (ttm)99.38B
Net Income (ttm)17.59B
Shares Out26.94M
EPS (ttm)685.72
PE Ratio8.24
Forward PE6.73
Dividend30.00 (0.53%)
Ex-Dividend DateDec 27, 2024
Volume291,365
Average Volume420,016
Open5,800.00
Previous Close5,780.00
Day's Range5,600.00 - 5,830.00
52-Week Range3,210.00 - 6,600.00
Beta0.64
RSI41.35
Earnings DateNov 14, 2025

About Meta Biomed

Meta Biomed Co., Ltd. engages in the research, development, and production of dental and surgical materials in South Korea, Asia, Europe, the United States, and Africa. The company's dental products include endodontics, dental equipment, restorative materials, and bone graft materials. It also offers suture products comprising multifilament and monofilament products; suture materials, such as functional and orthopedic suture materials; biomaterials, that includes polymer, multifilament yarn, 3D printing filaments, and bioceramic powder; and aux... [Read more]

Industry Dental Equipment and Supplies
Founded 1990
Employees 301
Stock Exchange KOSDAQ
Ticker Symbol 059210
Full Company Profile

Financial Performance

In 2024, Meta Biomed's revenue was 94.04 billion, an increase of 13.16% compared to the previous year's 83.10 billion. Earnings were 22.40 billion, an increase of 122.24%.

Financial Statements

News

There is no news available yet.